The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 351:399-402 July 22, 2004 Number 4
NextNext

Ductal Carcinoma in Situ of the Breast

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Burstein, H. J.
-PubMed Citation
To the Editor: One take-home message from the review article by Burstein et al. on ductal carcinoma in situ of the breast (April 1 issue)1 is that all women who have undergone breast-conserving surgery should receive routine radiotherapy. This is the impression that I have received from colleagues concerned about a 12 percent recurrence rate in their trial of wide excision alone for ductal carcinoma in situ.2 The pathobiologic events reviewed by Burstein et al. suggest that the treatment of ductal carcinoma in situ can be viewed as a late-stage intervention to prevent invasive breast cancer. The available randomized studies . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.